Literature DB >> 1723680

FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse.

K L Stark1, J A McMahon, A P McMahon.   

Abstract

We have used the polymerase chain reaction to clone from fetal cerebellar RNA a novel member of the fibroblast growth factor receptor family, FGFR-4. cDNAs encoding a full-length receptor were isolated and RNA expression examined in adult and fetal tissues by RNA blot analysis. Transcripts were detected in adult lung, liver and kidney and in fetal RNAs from 11.5 to 16.5 days post coitum (p.c.). In situ hybridization was performed to examine developmental expression. FGFR-4 RNA was expressed in definitive endoderm of the developing gut and extraembryonic endoderm of the yolk-sac from 8.5 to 14.5 days p.c. At early somite stages, FGFR-4 was also expressed in the myotomal component of the somite, and by 14.5 days p.c. in the myotomally derived skeletal muscle. No expression was seen at any stage in cardiac muscle. Several endodermal derivatives, the liver, lung and pancreas, expressed FGFR-4 at 14.5 days p.c. In addition, FGFR-4 RNA was detected in the adrenal cortex, collecting tubules of the kidney and condensing cartilage at this time. These results suggest that FGFR-4 is likely to have diverse roles in development, which may include regulation of definitive endoderm and skeletal muscle lineages.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723680     DOI: 10.1242/dev.113.2.641

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  39 in total

1.  Functional analysis of H-Ryk, an atypical member of the receptor tyrosine kinase family.

Authors:  R M Katso; R B Russell; T S Ganesan
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway.

Authors:  S Murakami; M Kan; W L McKeehan; B de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  RYK, a receptor tyrosine kinase-related molecule with unusual kinase domain motifs.

Authors:  C M Hovens; S A Stacker; A C Andres; A G Harpur; A Ziemiecki; A F Wilks
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

5.  FGFR4 and its novel splice form in myogenic cells: Interplay of glycosylation and tyrosine phosphorylation.

Authors:  Boguslaw A Kwiatkowski; Irina Kirillova; Robert E Richard; David Israeli; Zipora Yablonka-Reuveni
Journal:  J Cell Physiol       Date:  2008-06       Impact factor: 6.384

Review 6.  Role of fibroblast growth factors in elicitation of cell responses.

Authors:  C Laestander; W Engström
Journal:  Cell Prolif       Date:  2013-12-20       Impact factor: 6.831

7.  Pax3 regulation of FGF signaling affects the progression of embryonic progenitor cells into the myogenic program.

Authors:  Mounia Lagha; Jay D Kormish; Didier Rocancourt; Marie Manceau; Jonathan A Epstein; Kenneth S Zaret; Frédéric Relaix; Margaret E Buckingham
Journal:  Genes Dev       Date:  2008-07-01       Impact factor: 11.361

8.  Differential regulation of potassium currents by FGF-1 and FGF-2 in embryonic Xenopus laevis myocytes.

Authors:  R Chauhan-Patel; A E Spruce
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

9.  The signals of FGFs on the neurogenesis of embryonic stem cells.

Authors:  Ching-Wen Chen; Chin-San Liu; Ing-Ming Chiu; Shih-Cheng Shen; Hung-Chuan Pan; Kun-Hsiung Lee; Shinn-Zong Lin; Hong-Lin Su
Journal:  J Biomed Sci       Date:  2010-04-29       Impact factor: 8.410

10.  Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study.

Authors:  Hongmei Nan; Abrar A Qureshi; David J Hunter; Jiali Han
Journal:  BMC Cancer       Date:  2009-06-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.